Understanding and managing psychological disorders in patients with inflammatory bowel disease: a practical guide
Klaartje Kok(Barts Health NHS Trust), David S. Rampton(Royal London Hospital), Peter Martin(Northwestern University), Peter Byrne(East London NHS Foundation Trust), Ana R Ibarra(Barts Health NHS Trust)
Cited by 16
Related Papers
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k
Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results
|Blood|2015|408
Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma
|Journal of Clinical Oncology|2009|340
Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma
|Journal of Clinical Oncology|2010|319